FREE PREMIUM SUBSCRIPTION FOR 14 DAYS!
Which way will EDGE go? Request

EDGE Stock Risk

This stock may move much during the day (volatility) and with a large prediction interval from the Bollinger Band this stock is considered to be "high risk". During the last day, the stock moved $0.45 between high and low, or 4.38%. For the last week, the stock has had a daily average volatility of 7.51%.

Our recommended stop-loss: $10.10 (-5.34%) (This stock has high daily movements and this gives high risk. There is a sell signal from a pivot top found 33 day(s) ago.)

Overall risk:

Very Low Low Medium High Very High

* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.
RSImin/max Values: [ 25 - 75 ] RSI14 is 58 and the stock is currently not being overbought or oversold

Edge Therapeutics stock upgraded from Sell Candidate to Hold/Accumulate after Friday trading session. (Updated on July 30, 2021)


Hold candidate since 2021-07-30

The Edge Therapeutics stock price gained 0.95% on the last trading day (Friday, 30th Jul 2021), rising from $10.57 to $10.67. , and has now gained 4 days in a row. It will be exciting to see whether it manages to continue gaining or take a minor break for the next few days. During the day the stock fluctuated 4.38% from a day low at $10.27 to a day high of $10.72. The price has been going up and down for this period, and there has been a 11.26% gain for the last 2 weeks. Volume fell on the last day by -158 thousand shares and in total, 249 thousand shares were bought and sold for approximately $2.65 million. You should take into consideration that falling volume on higher prices causes divergence and may be an early warning about possible changes over the next couple of days.

The stock lies in the middle of a very wide and strong rising trend in the short term and a further rise within the trend is signaled. Given the current short-term trend, the stock is expected to rise 49.78% during the next 3 months and, with a 90% probability hold a price between $13.48 and $23.40 at the end of this 3-month period.

Signals & Forecast

The Edge Therapeutics stock holds buy signals from both short and long-term moving averages giving a positive forecast for the stock, but the stock has a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections down, there will be some support from the lines at $10.04 and $10.63. A breakdown below any of these levels will issue sell signals. Furthermore, there is a buy signal from the 3 months Moving Average Convergence Divergence (MACD). Volume fell during the last trading day despite gaining prices. This causes a divergence between volume and price and it may be an early warning. The stock should be watched closely. Some negative signals were issued as well, and these may have some influence on the near short-term development. A sell signal was issued from a pivot top point on Monday, June 14, 2021, and so far it has fallen -17.03%. Further fall is indicated until a new bottom pivot has been found.

Support, Risk & Stop-loss

On the downside, the stock finds support just below today's level from accumulated volume at $9.40 and $9.20. There is natural risk involved when a stock is testing a support level, since if this is broken, the stock then may fall to the next support level. In this case, Edge Therapeutics finds support just below today's level at $9.40. If this is broken, then the next support from accumulated volume will be at $9.20 and $8.33.

This stock may move much during the day (volatility) and with a large prediction interval from the Bollinger Band this stock is considered to be "high risk". During the last day, the stock moved $0.45 between high and low, or 4.38%. For the last week, the stock has had a daily average volatility of 7.51%.

Our recommended stop-loss: $10.10 (-5.34%) (This stock has high daily movements and this gives high risk. There is a sell signal from a pivot top found 33 day(s) ago.)

Is Edge Therapeutics stock A Buy?

Edge Therapeutics holds several positive signals, but we still don't find these to be enough for a buy candidate. At the current level, it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development. We have upgraded our analysis conclusion for this stock since the last evaluation from a Sell to a Hold/Accumulate candidate.

Current score: 0.218

Predicted Opening Price for Edge Therapeutics of Monday, August 2, 2021

The predicted opening price is based on yesterday's movements between high, low, and the closing price.

Fair opening price August 2, 2021 Current price
$10.55 $10.67 (Overvalued)
Hold/Accumulate Upgraded

Remember To Visit Our YouTube Channel

Volatility
7.51 %
Daily Average Volatility
Overall Risk

Very High
High
Medium
Low
Very Low

Support & Resistance

Resistance: $11.16
Price: $10.67
Support: $9.40

Fibonacci Support & Resistance Levels

Level Price Change
Resistance 11.00 3.12 %
10.83 1.51 %
10.73 0.52 %
Current price: 10.67
Support 10.38 -2.70 %
10.28 -3.70 %
10.10 -5.31 %

Accumulated Volume Support & Resistance Levels

Level Price Chg %
Resistance 11.52 7.97 %
11.30 5.90 %
11.16 4.59 %
Current price 10.67
Support 9.40 -11.90%
9.20 -13.78%
8.33 -21.93%

Click to get the best stock tips daily for free!

About Edge Therapeutics

Edge Therapeutics, Inc., a clinical-stage biotechnology company, discovers, develops, and commercializes hospital-based therapies for acute life-threatening neurological conditions. Its lead product includes EG-1962, a polymer-based microparticle used for the treatment of aneurysmal subarachnoid hemorrhage. The company also develops EG-1964 for the management of chronic subdural hematoma as a prophylactic treatment to prevent recurrent bleeding. ... Read more

Golden Star Signal

This unique signal uses moving averages and adds special requirements that convert the very good Golden Cross into a Golden Star.

This signal is rare and, in most cases, gives substantial returns. From 10 000+ stocks usually only a few will trigger a Golden Star Signal per day!

Get access to Golden Star list now!

StockInvest.usJoin 95.000+ Happy Subscribers

Don't miss out on the runners!

Get The StockInvest.Us Newsletter

StockInvest.usStock Podcast

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT